Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Pitney Bowes (PBI)

Pitney Bowes adds La Vonda Williams to board, names her to Strategic Review Committee

Neutral Impact 3 of 5 leadership Written later

Pitney Bowes appointed La Vonda Williams, former CFO of Onegevity Health, to its Board of Directors effective July 21, 2026. She joins the Audit, Governance and Strategic Review Committees, and the filing describes the Strategic Review Committee as formed in connection with the company's previously announced strategic review process.

Key points

  • Appointed to the Board on July 21, 2026, with a $200,000 annual cash retainer plus committee fees under the standard non-management director arrangements
  • Committee roles: Audit Committee and Governance Committee (additional $20,000 and $12,000 annual cash retainers), and Strategic Review Committee (extra equity grant of $278,000, prorated to $225,446)
  • Also receives an annual equity grant of $100,000, prorated to $81,095 for her mid-year start, that vests one year later
  • Filing states no arrangements or understandings tied to her appointment and no related-party transactions under Item 404(a)

The filing

CompanyPitney Bowes (PBI)
Form8-K, current report
Filed with the SECJul 27, 2026, 8:05 AM ET
Accession number0001628280-26-049667

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 27, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.